Publications

You can use the filters to show only results that match your interests

173 publications by Advisory Council on the Misuse of Drugs ×

Get updates to this list email feed

Copy and paste this URL in to your feed reader

1. ACMD members' register of interests

   • 28 September 2017
   • ACMD
   • Corporate report

2. Commissioning impact on drug treatment

   • 6 September 2017
   • ACMD
   • Corporate report

3. Home Office Science non-departmental public bodies (NDPBs): triennial review

   • 20 July 2017
   • Home Office, ACMD, NDNAD, ASC and Biometrics and Forensics Ethics Group
   • Corporate report

4. Psychoactive Substances Bill: evaluation review

   • 14 July 2017
   • ACMD
   • Corporate report

5. Drug strategy 2016: development review

   • 14 July 2017
   • ACMD
   • Corporate report

6. Methiopropamine: a review of the evidence of use and harm

   • 16 June 2017
   • ACMD
   • Corporate report

7. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

   • 23 March 2017
   • ACMD
   • Policy paper

8. Further advice on U-47,700, etizolam and other designer benzodiazepines

   • 10 March 2017
   • Home Office and ACMD
   • Correspondence

9. Prescribing of controlled drugs by therapeutic radiographers: further advice

   • 19 January 2017
   • ACMD
   • Correspondence

10. Advice on U-47,700, etizolam and other designer benzodiazepines

    • 21 December 2016
    • ACMD
    • Correspondence

11. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • 21 December 2016
    • ACMD
    • Correspondence

12. Misuse of Drugs Regulations 2001: impact on research

    • 16 December 2016
    • ACMD
    • Correspondence

13. Plant cannabinoids: ACMD report

    • 16 December 2016
    • ACMD
    • Policy paper

14. Diversion & illicit supply of medicines

    • 15 December 2016
    • ACMD
    • Policy paper

15. Reducing opioid-related deaths in the UK

    • 12 December 2016
    • ACMD
    • Independent report

16. 'Third generation' synthetic cannabinoids

    • 15 November 2016
    • ACMD
    • Correspondence

17. Temporary class drug order on methiopropamine

    • 30 September 2016
    • ACMD
    • Correspondence

18. Problems for Ageing Drug Users Working Group: public meeting invitation

    • 9 September 2016
    • ACMD
    • Promotional material

19. Independent prescribing of controlled drugs by therapeutic radiographers

    • 5 September 2016
    • ACMD
    • Correspondence

20. ACMD work programme for 2016

    • 27 April 2016
    • ACMD
    • Correspondence

21. ACMD review of alkyl nitrites (poppers)

    • 16 March 2016
    • ACMD
    • Correspondence

22. Advice on the anticonvulsant drugs Pregabalin and Gabapentin

    • 14 January 2016
    • ACMD
    • Correspondence

23. Advice on the steroid Dienedione

    • 14 January 2016
    • ACMD
    • Correspondence

24. ACMD’s temporary class drug order report on Methiopropamine

    • 26 November 2015
    • ACMD
    • Correspondence

25. ACMD public meeting: 24 November 2015

    • 17 November 2015
    • ACMD
    • Form

26. ACMD’s final advice on definitions for the Psychoactive Substances Bill

    • 23 October 2015
    • ACMD
    • Correspondence

27. How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?

    • 23 October 2015
    • ACMD
    • Policy paper

28. Ministerial response to ACMD report on cocaine misuse

    • 17 September 2015
    • DH, Home Office and ACMD
    • Correspondence

29. Ministerial response to ACMD report on nitrous oxide misuse

    • 17 September 2015
    • DH, Home Office and ACMD
    • Correspondence

30. ACMD interim advice: diversion and illicit supply of medicines

    • 27 August 2015
    • ACMD
    • Correspondence

31. ACMD report on definitions for the Psychoactive Substances Bill

    • 17 August 2015
    • ACMD
    • Correspondence

32. ACMD advice about Northern Ireland’s continued maintenance of the Addicts Index

    • 17 August 2015
    • ACMD
    • Correspondence

33. ACMD letter to the Home Secretary: Psychoactive Substances Bill, 13 July 2015

    • 13 July 2015
    • ACMD
    • Correspondence

34. ACMD letter to the Home Secretary: Psychoactive Substances Bill

    • 3 July 2015
    • ACMD
    • Correspondence

35. Letter to Mike Penning on methylphenidate-based novel psychoactive substances

    • 25 June 2015
    • ACMD
    • Correspondence

36. ACMD open meeting registration form: 2 July 2015

    • 22 June 2015
    • ACMD
    • Form

37. Proposals to review and amend specific provisions under the Misuse of Drugs Regulations 2001

    • 25 March 2015
    • ACMD
    • Correspondence

38. Electronic prescribing service for schedules 2 and 3 controlled drugs

    • 25 March 2015
    • ACMD
    • Correspondence

39. Consolidation of the Misuse of Drugs (Designation) Order 2001

    • 13 March 2015
    • Home Office and ACMD
    • Correspondence

40. Cocaine powder: review of its prevalence, patterns of use and harm

    • 12 March 2015
    • ACMD
    • Policy paper